Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

11th World Congress on Virology and Infectious Diseases

Tokyo, Japan

Jie Ding

Jie Ding

Nanjing Municipal Center for Disease ,China

Title: The concurrent circulation of multiple recombinant norovirus genotypes in 2016/17 and 2017/18 epidemic season in Nanjing, China

Biography

Biography: Jie Ding

Abstract

Noroviruses are the most common cause of acute gastroenteritis (AGE) worldwide, remaining a significant public health problem in both high-income countries and developing countries. In 2016/17 norovirus epidemic season, 34 out of 40 AGE clusters/ outbreaks were laboratory-conformed as GII positive, outnumbering the total number of norovirus clusters/ outbreaks in the past 3 epidemic seasons in Nanjing area. The unusual active norovirus activity and the sharp rise in the AGE outbreaks were presumably due to the predominance of an emergent genotype GII.P16/GII.2 and the concurrent circulation of several other genotypes among which GII.P7-GII.6 and GII.P22-GII.5 were rare recombinant strains. The previously predominant novel GII.P17-GII.17 came second as one of the causative genotypes. Altogether 27.5% of the norovirus outbreaks due to GII.P16-GII.2 strains occurred in kindergartens and elementary schools.The intervariant GII.4 recombinant form GII.P4_New Orleans_ 2009/ GII.4_Sydney_2012, which was considered to have the potential to become an epidemic or pandemic variant, had not been detected. In the current 2017/18 winter season, however, the circulating norovirus genotypes which have caused the majority of norovirus AGE outbreaks are GII.P16/GII.2 and GII.Pe-GII.4. In conclusion, we have observed the tendency that multiple genotypes instead of one single predominant variant have been responsible for the seasonal norovirus epidemic since GII.4 decreased its prevalence from 2014 onwards. The  novel GII.P17-GII.17 replaced GII.4 in 2014/15 winter season and the emergent GII.P16/GII.2 surpassed the  novel GII.P17-GII.17 in 2016/17 winter season. It remains unknown, however, whether the continuous emergence of novel norovirus variants capable of spreading may occur.